Literature DB >> 17925326

Transcranial Doppler scanning and the assessment of stroke risk in children with HbSC [corrected] disease.

Colin R Deane1, David Goss, Sandra O'Driscoll, Sarah Mellor, Keith R E Pohl, Moira C Dick, Sue E Height, David C Rees.   

Abstract

OBJECTIVE: To assess the role of transcranial Doppler (TCD) scanning in assessing the risk of stroke in children with haemoglobin SC (HbSC) disease. TCD scanning has an established role in primary stroke prevention in sickle cell anaemia but its value in HbSC is unknown.
DESIGN: A retrospective audit of routinely performed TCD scans and routinely collected clinical data.
SETTING: A paediatric sickle cell clinic in a teaching hospital in south London, UK. PATIENTS: 46 children with HbSC disease who have undergone routinely performed TCD scans and steady-state blood tests. MAIN OUTCOME MEASURES: The time-averaged mean of the maximum velocity (TAMMV) in the middle cerebral artery circulation correlated with clinical and laboratory data.
RESULTS: The mean TAMMV was 94 cm/s, with a 98(th) centile of 128 cm/s. This is significantly less than the published ranges for HbSS, with a mean reading of 129 cm/s. One child had a stroke at the age of 5 years, when her TAMMV was measured at 146 cm/s.
CONCLUSIONS: Further studies are needed to assess stroke risk in HbSC disease, but we suggest that TCD measurements are potentially useful in this condition, and that readings greater than 128 cm/s are abnormally high and warrant further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17925326     DOI: 10.1136/adc.2007.125799

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

Review 1.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

2.  The clinical significance of K-Cl cotransport activity in red cells of patients with HbSC disease.

Authors:  David C Rees; Swee Lay Thein; Anna Osei; Emma Drasar; Sanjay Tewari; Anke Hannemann; John S Gibson
Journal:  Haematologica       Date:  2015-03-06       Impact factor: 9.941

3.  The significance of inadequate transcranial Doppler studies in children with sickle cell disease.

Authors:  Simon Greenwood; Colin Deane; Oliver L Rees; Ben Freedman; Suresh Kumar; Naser Ben Ramadan; Sarah Wilkinson; Grant Marais; Julie Lord; Subarna Chakravorty; Susan E Height; Kate Gardner; David C Rees
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

4.  Laboratory and Genetic Biomarkers Associated with Cerebral Blood Flow Velocity in Hemoglobin SC Disease.

Authors:  Rayra Pereira Santiago; Camilo Vieira; Corynne Stephanie Ahouefa Adanho; Sanzio Silva Santana; Caroline Conceição Guarda; Camylla Vilas Boas Figueiredo; Luciana Magalhães Fiuza; Thassila Nogueira Pitanga; Junia Raquel Dutra Ferreira; Milena Magalhães Aleluia; Rodrigo Mota Oliveira; Dalila Luciola Zanette; Isa Menezes Lyra; Marilda Souza Goncalves
Journal:  Dis Markers       Date:  2017-07-16       Impact factor: 3.434

5.  Primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening program.

Authors:  Raffaella Colombatti; Giorgio Meneghetti; Mario Ermani; Marta Pierobon; Laura Sainati
Journal:  Ital J Pediatr       Date:  2009-06-22       Impact factor: 2.638

6.  Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With Thrombocytosis.

Authors:  Abdolhamid Shariat; Masoume Nazeri; Amin Abolhasani Foroughi; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

7.  Pattern of Cerebral Blood Flow Velocity Using Transcranial Doppler Ultrasonography in Children with Sickle Cell Disorder in Lagos State, Nigeria.

Authors:  Motunrayo Oluwabukola Adekunle; Adeola Barakat Animasahun; Ijeoma Nnenna Diaku-Akinwumi; Olisamedua Fidelis Njokanma
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-14       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.